
Sign up to save your podcasts
Or


In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 2024 and beyond.
By J.P. Morgan Asset Management4.1
8989 ratings
In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 2024 and beyond.

967 Listeners

201 Listeners

95 Listeners

796 Listeners

290 Listeners

90 Listeners

262 Listeners

191 Listeners

68 Listeners

1,309 Listeners

77 Listeners

443 Listeners

29 Listeners

81 Listeners

27 Listeners